African Trypanosomiasis - Pipeline Review, H2 2017

SKU ID : GMD-11218074 | Publishing Date : 22-Aug-2017 | No. of pages : 47

Detailed TOC of African Trypanosomiasis - Pipeline Review, H2 2017

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
African Trypanosomiasis - Overview
African Trypanosomiasis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
African Trypanosomiasis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
African Trypanosomiasis - Companies Involved in Therapeutics Development
Merck & Co Inc
Novartis AG
Sanofi
Scynexis Inc
African Trypanosomiasis - Drug Profiles
AN-5568 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CBL-0137 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DDD-100097 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
fexinidazole - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GNF-6702 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
melarsoprol hydroxypropylbetadex - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MS-08 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Peptides for Sleeping Sickness - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for African Trypanosomiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Infectious Diseases - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Sleeping Sickness - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Trypanosomiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Lanosterol 14 alpha-Demethylase for Chagas Disease, Leishmaniasis and African Trypanosomiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Leucyl-tRNA Synthetase (LeuRS) for Human African Trypanosomiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit N-Myristoyltransferase for African Trypanosomiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Variant Surface Glycoprotein for African Trypanosomiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
African Trypanosomiasis - Dormant Projects
African Trypanosomiasis - Discontinued Products
African Trypanosomiasis - Product Development Milestones
Featured News & Press Releases
Aug 30, 2016: UGA researchers discover a drug for a tropical disease
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Figures, Tables and Charts Available in African Trypanosomiasis - Pipeline Review, H2 2017

List of Tables
Number of Products under Development for African Trypanosomiasis, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Products under Development by Companies, H2 2017
Products under Development by Universities/Institutes, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
African Trypanosomiasis - Pipeline by Merck & Co Inc, H2 2017
African Trypanosomiasis - Pipeline by Novartis AG, H2 2017
African Trypanosomiasis - Pipeline by Sanofi, H2 2017
African Trypanosomiasis - Pipeline by Scynexis Inc, H2 2017
African Trypanosomiasis - Dormant Projects, H2 2017
African Trypanosomiasis - Discontinued Products, H2 2017